Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Philippa Gardner

Philippa Gardner
Healthcare Analyst

Lala Gregorek

Lala Gregorek
Director of Healthcare Research and Strategy

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Daniel Wilkinson

Daniel Wilkinson
Analyst

By region

Recent initiations

LifeWatch Biondvax Pharmaceuticals
Quantum Genomics RedHill Biopharma
Pluristem Therapeutics Immunovia

Recent QuickViews

Nuevolution

Delivering on promises

Pharmaceutical & healthcare | published 04/01/2017
Nuevolution

Amgen deal: A significant step forward

Pharmaceutical & healthcare | published 23/11/2016
aap Implantate

Progression of LOQTEQ portfolio

Pharmaceutical & healthcare | published 21/11/2016
Epigenomics

Q316 results and business update

Pharmaceutical & healthcare | published 11/11/2016

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Abzena

New ThioBridge licence agreement

Flash note | Pharmaceutical & healthcare | 20/01/2017

Abzena has achieved a significant licensing deal for its proprietary site-specific ThioBridge antibody drug conjugate (ADC) linker technology with a San…

AFT Pharmaceuticals

Updates on several products

Update | Pharmaceutical & healthcare | 20/01/2017

AFT Pharma recently made announcements affecting several of its marketed products. Importantly, the Australian Therapeutic Goods Administration (TGA) has…

e-Therapeutics

Embarking on the next phase: Deals and data

Update | Pharmaceutical & healthcare | 16/01/2017

e-Therapeutics (ETX) has appointed a new CEO, Dr Raymond Barlow, who will join the company by 1 May 2017. He brings significant R&D and business development…

Pixium Vision

Pixium completes 10th implantation of Iris II study

Flash note | Pharmaceutical & healthcare | 12/01/2017

Pixium announced this week that it has completed the 10th and final implantation as part of its ongoing European Iris-II study. This trial began in January…

RedHill Biopharma

Co-promotion deal and key catalysts in 2017

Update | Pharmaceutical & healthcare | 12/01/2017

On 27 December the company completed a successful $38m fund-raising and announced a co-promotion deal in the US, which may turn RedHill into a commercial-stage,…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies